×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [16]
内容类型
期刊论文 [10]
会议论文 [6]
发表日期
2017 [1]
2014 [1]
2013 [4]
2012 [4]
2011 [6]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共16条,第1-10条
帮助
限定条件
专题:复旦大学上海医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
期刊论文
JOURNAL OF HEPATOLOGY, 2017, 卷号: 67, 期号: 2
作者:
Huang, Ao
;
Zhao, Xin
;
Yang, Xin-Rong
;
Li, Fu-Qiang
;
Zhou, Xin-Lan
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
Intratumoral heterogeneity (ITH)
Targeted deep sequencing (TDS)
Circulating cell-free DNA (cfDNA)
Target therapy
Hepatocellular carcinoma (HCC)
Glyoxalase 1 is up-regulated in hepatocellular carcinoma and is essential for HCC cell proliferation
期刊论文
BIOTECHNOLOGY LETTERS, 2014, 卷号: 36, 期号: 2
作者:
Hu, Xiaohui
;
Yang, Xianmei
;
He, Quanze
;
Chen, Qi
;
Yu, Long
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/19
Glo1
Glyoxalase
Hepatocellular carcinoma
Methylglyoxal
Therapeutic target
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction
期刊论文
Journal of Clinical Oncology, 2013, 卷号: 31
作者:
Marrero J.A., Lencioni R., Ye S.-L., Kudo M., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Geschwind J.-F., De Guevara L.L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Ven
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Evaluation of TGF beta, XPO4, elF5A2 and ANGPTL4 as biomarkers in HCC
期刊论文
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 卷号: 5, 期号: 1
作者:
Zhang, Hao
;
Wei, Shi
;
Ning, Song
;
Jie, Yungliu
;
Ru, Yukang
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
hepatocellular carcinoma
XPO4
TGF beta 1
ANGPTL4
elF5A2
biomarker
Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sortreated patients (pts): Clinical findings in pts with liver dysfunction
会议论文
作者:
Marrero, Jorge A.
;
Lencioni, Riccardo
;
Ye, Sheng-Long
;
Kudo, Masatoshi
;
Bronowicki, Jean-Pierre
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Final analysis of GIDEON [Global investigation of therapeutic decisions in hepatocellular carcinoma (HCC) and of its treatment with sorafenib]: Safety and outcomes of using prior transarterial chemoembolization (TACE)
期刊论文
CardioVascular and Interventional Radiology, 2013
作者:
Lencioni R., Kudo M., Marrero J., Venook A., Ye S.-L., Bronowicki J.-P., Chen X.-P., Dagher L., Furuse J., Ladr贸n De Guevara L., Papandreou C., Sanyal A.J., Takayama T., Yoon S.K., Nakajima K., Geschw
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/19
GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA [HCC] AND OF ITS TREATMENT WITH SORAFENIB [SOR]) 2ND INTERIM ANALYSIS (IA): SUBGROUP ANALYSIS BY DISEASE ETIOLOGY
会议论文
作者:
Bronowicki, J.
;
Ye, S.
;
Kudo, M.
;
Marrero, J.
;
Venook, A.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC (uHCC) and of Its Treatment with Sorafenib (GIDEON): Differences in AE reporting across physician specialties
期刊论文
Journal of Clinical Oncology, 2012, 卷号: 30
作者:
Venook A.P., Lencioni R., Marrero J.A., Kudo M., Nakajima K., Ye S.-L., Cihon F.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/19
Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study
期刊论文
Journal of Vascular and Interventional Radiology, 2012, 卷号: 23
作者:
Geschwind J.F., Lencioni R., Marrero J., Venook A., Ye S., Nakajima K., Kudo M.
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/19
Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): Second interim analysis of the Global Investigation of Therapeutic Decisions in HCC and of Its Treatment with Sorafenib (GIDEON) study
期刊论文
Journal of Clinical Oncology, 2012, 卷号: 30
作者:
Geschwind J.H., Lencioni R., Marrero J.A., Venook A.P., Ye S.-L., Nakajima K., Cihon F., Kudo M.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/19
©版权所有 ©2017 CSpace - Powered by
CSpace